Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis. (Record no. 19199673)

MARC details
000 -LEADER
fixed length control field 01274 a2200361 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515190834.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201004s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1398-9995
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1398-9995.2009.02147.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Brinkmann, F
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100408
245 00 - TITLE STATEMENT
Title Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Allergy
Date of publication, distribution, etc. Jan 2010
300 ## - PHYSICAL DESCRIPTION
Extent 134-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adrenal Cortex Hormones
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Asthmatic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Anti-Idiotypic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aspergillosis, Allergic Bronchopulmonary
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cystic Fibrosis
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Omalizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Respiratory Function Tests
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schwerk, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hansen, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ballmann, M
773 0# - HOST ITEM ENTRY
Title Allergy
Related parts vol. 65
-- no. 1
-- p. 134-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1398-9995.2009.02147.x">https://doi.org/10.1111/j.1398-9995.2009.02147.x</a>
Public note Available from publisher's website

No items available.